Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Revenue

Sartorius Stedim Biotech had revenue of 772.20M EUR in the quarter ending December 31, 2025, with 2.78% growth. This brings the company's revenue in the last twelve months to 2.22B, down -22.21% year-over-year. In the year 2025, Sartorius Stedim Biotech had annual revenue of 2.97B with 6.74% growth.

• Revenue (ttm): 2.22B
• Revenue Growth: -22.21%
• P/S Ratio: 5.15
• Revenue / Employee: 298.17K
• Employees: 10,265
• Market Cap: 15.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.97B	187.50M	6.74%
Dec 31, 2024	2.78B	4.50M	0.16%
Dec 31, 2023	2.78B	-717.20M	-20.53%
Dec 31, 2022	3.49B	605.70M	20.98%
Dec 31, 2021	2.89B	976.92M	51.15%
Dec 31, 2020	1.91B	469.51M	32.59%
Dec 31, 2019	1.44B	228.42M	18.84%
Dec 31, 2018	1.21B	131.12M	12.13%
Dec 31, 2017	1.08B	29.42M	2.80%
Dec 31, 2016	1.05B	167.28M	18.92%
Dec 31, 2015	884.33M	200.81M	29.38%
Dec 31, 2014	683.52M	95.15M	16.17%
Dec 31, 2013	588.38M	44.41M	8.16%
Dec 31, 2012	543.96M	66.66M	13.97%
Dec 31, 2011	477.30M	44.35M	10.24%
Dec 31, 2010	432.95M	31.72M	7.91%
Dec 31, 2009	401.23M	33.24M	9.03%
Dec 31, 2008	368.00M	99.16M	36.88%
Dec 31, 2007	268.84M	177.46M	194.22%
Dec 31, 2006	91.37M	5.63M	6.56%
Dec 31, 2005	85.74M	-	-